Tesamorelin (brand name Egrifta) is an FDA-approved drug for reducing visceral adiposity, particularly in HIV patients, and is taken about three times per week.

Every Sunday: the week’s new conflicts and verdict changes — and nothing else.

Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.